- Home
- ARVN vs ERII Comparison
ARVN vs ERII Comparison
Compare ARVN & ERII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARVN | ERII |
|---|---|---|
| Founded | 2015 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 781.0M | 740.3M |
| IPO Year | 2018 | 2008 |
Fundamental Metrics
Financial Performance| Metric | ARVN | ERII |
|---|---|---|
| Price | $12.24 | $14.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 23 | 2 |
| Target Price | ★ $18.14 | $16.50 |
| AVG Volume (30 Days) | ★ 792.5K | 388.8K |
| Earning Date | 02-10-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.56 |
| EPS | N/A | ★ 0.36 |
| Revenue | ★ $312,300,000.00 | $135,191,000.00 |
| Revenue This Year | $11.17 | $5.93 |
| Revenue Next Year | N/A | $8.97 |
| P/E Ratio | ★ N/A | $40.10 |
| Revenue Growth | ★ 93.86 | 0.10 |
| 52 Week Low | $5.90 | $10.86 |
| 52 Week High | $20.38 | $18.32 |
Technical Indicators
Market Signals| Indicator | ARVN | ERII |
|---|---|---|
| Relative Strength Index (RSI) | 53.70 | 50.87 |
| Support Level | $11.88 | $14.04 |
| Resistance Level | $12.79 | $14.50 |
| Average True Range (ATR) | 0.53 | 0.35 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 68.02 | 77.56 |
Price Performance
Historical ComparisonAbout ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About ERII Energy Recovery Inc.
Energy Recovery Inc is an engineering-driven technology company. It is engaged in engineering, designing, manufacturing and supplying solutions that make industrial processes more efficient and sustainable. The company operates in three segments, Water, Emerging Technologies and Corporate. It offers energy recovery devices (ERDs) and pumps as well as related products and services to the reverse osmosis desalination market. The company derives a majority of the revenue from the Water segment. Geographically, the company operates in the U.S. and other international countries.